Indaptus Therapeutics (INDP) Other Non Operating Income (2024 - 2026)

Indaptus Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $28672.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 28.55% year-over-year to $28672.0; the TTM figure through Mar 2026 stood at $126561.0 (down 48.82% YoY), while the FY2025 annual figure was $138018.0, down 59.85% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $28672.0, down from $43254.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $93618.0 in Q2 2024, with the low at $15547.0 in Q2 2025.
• The 3-year median for Other Non Operating Income is $40326.0 (2024), against an average of $46731.5.
• Peak annual rise in Other Non Operating Income reached 6.74% in 2025, while the deepest fall reached 83.39% in 2025.
• Indaptus Therapeutics' Other Non Operating Income stood at $40523.0 in 2024, then gained by 6.74% to $43254.0 in 2025, then sank by 33.71% to $28672.0 in 2026.
• Business Quant data shows INDP's Other Non Operating Income at $28672.0 in Q1 2026, $43254.0 in Q4 2025, and $39088.0 in Q3 2025.